BioengineeringbioRxivPreprint
✦ In-depth digest
BioPathfinder: Evidence-guided multi-agent platform enables hypothesis discovery for CAR-T engineering
Shubing Wang, Yan-Ruide Li, Qian Wang…·Debiao Li
A provenance-tracked multi-agent system curated 57 CAR-T patient scRNA-seq studies, generated reviewable hypotheses, and prioritized KLRC1/NKG2A, whose blockade improved CD8+ CAR-T antitumour activity in a Raji xenograft model.